Ascendis Pharma A/S
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.About ASND
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs.
ASND Key Statistics
Stock Snapshot
Ascendis Pharma A/S(ASND) stock is priced at $272.89, giving the company a market capitalization of 17.81B. It carries a P/E multiple of 19.55.
On 2026-09-03, Ascendis Pharma A/S(ASND) stock moved within a range of $265.87 to $274.10. With shares now at $272.89, the stock is trading +2.6% above its intraday low and -0.4% below the session's peak.
Trading volume for Ascendis Pharma A/S(ASND) stock has reached 1.02M, versus its average volume of 484.33K.
Over the past 52 weeks, Ascendis Pharma A/S(ASND) stock has traded between a high of $282.15 and a low of $186.05.
Over the past 52 weeks, Ascendis Pharma A/S(ASND) stock has traded between a high of $282.15 and a low of $186.05.
ASND News
New insider activity at Ascendis Pharma ( (ASND) ) has taken place on September 3, 2026. Ascendis Pharma director Lars Holtug has recently trimmed his holdings...
Oppenheimer raised the firm’s price target on Ascendis Pharma to $312 from $304 and keeps an Outperform rating on the shares. The firm has revised its Ascendis...
...
Analyst ratings
100%
of 22 ratingsMore ASND News
Ascendis Pharma (NasdaqGS:ASND) and BioMarin Pharmaceutical reached a global settlement and licensing agreement resolving all patent disputes over Yuviwel and n...
Ascendis Pharma ( (ASND) ) has shared an announcement. On August 31, 2026, Ascendis Pharma announced a binding term sheet for a global settlement and license a...
H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Ascendis Pharma today and set a price target of $345.00. Mitchell Kapoor has given his Buy ra...
BioMarin (BMRN) announced that it has entered into binding terms with Ascendis Pharma (ASND), resolving the patent and ancillary disputes pending globally, incl...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.